User contributions
From OpenWetWare
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 14:24, 17 April 2013 (hist) (diff) CH391L/S2013 (→Due April 17, 2013)
- 14:19, 17 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 17 2013 (top)
- 01:26, 17 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 17 2013
- 01:24, 17 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 17 2013
- 00:53, 17 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 17 2013
- 00:50, 17 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 17 2013 (→Referances)
- 00:43, 17 April 2013 (hist) (diff) N CH391L/S2013 Hala Ouzon April 17 2013 (New page: '''Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta (1)''' =='''Background and Introduction:'''== Crosslinks in DNA occur when various e...)
- 00:41, 17 April 2013 (hist) (diff) CH391L/S2013 (→Due April 17, 2013)
- 23:31, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Experimental Methods and Results:) (top)
- 23:31, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Background and Introduction:)
- 23:27, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Background and Introduction:)
- 23:26, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Background and Introduction:)
- 23:24, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Background and Introduction:)
- 23:23, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Experimental Methods and Results:)
- 23:21, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Experimental Methods and Results:)
- 23:12, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013
- 23:11, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013
- 23:11, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013 (→Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta (1))
- 23:09, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 10 2013
- 23:03, 9 April 2013 (hist) (diff) N CH391L/S2013 Hala Ouzon April 10 2013 (New page: '''Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta''' (1) '''Background and Introduction:''' Crosslinks in DNA occur when various exoge...)
- 23:02, 9 April 2013 (hist) (diff) CH391L/S2013 (→Due April 10, 2013)
- 23:01, 9 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon April 09 2013 (top)
- 22:39, 9 April 2013 (hist) (diff) N Image:Figure4-5.jpg ([1]) (top)
- 22:38, 9 April 2013 (hist) (diff) N Image:Figure4-4.jpg ([1]) (top)
- 22:37, 9 April 2013 (hist) (diff) N Image:Figure4-3.jpg ((5)) (top)
- 22:36, 9 April 2013 (hist) (diff) N Image:Figure4-2.jpg (top)
- 22:36, 9 April 2013 (hist) (diff) N Image:Figure4-1.jpg (top)
- 18:15, 9 April 2013 (hist) (diff) N CH391L/S2013 Hala Ouzon April 09 2013 (New page: '''Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta''' (1))
- 18:11, 9 April 2013 (hist) (diff) CH391L/S2013 (→Due April 10, 2013)
- 00:58, 3 April 2013 (hist) (diff) CH391L/S2013 Hala Ouzon March 20 2013 (top)
- 00:55, 3 April 2013 (hist) (diff) CH391L/S2013 (→Due March 27, 2013)
- 12:12, 20 March 2013 (hist) (diff) CH391L/S2013 Hala Ouzon March 20 2013
- 17:05, 14 March 2013 (hist) (diff) CH391L/S2013 Hala Ouzon March 20 2013 (Removing all content from page)
- 17:03, 14 March 2013 (hist) (diff) N CH391L/S2013 Hala Ouzon March 20 2013 (New page: Introduction)
- 17:02, 14 March 2013 (hist) (diff) CH391L/S2013 (→Due March 20, 2013)
- 17:02, 14 March 2013 (hist) (diff) CH391L/S2013 (→Due February 27, 2013)
- 16:49, 14 March 2013 (hist) (diff) User:Hala Ouzon-Shubeita (→Useful links) (top)
- 16:44, 14 March 2013 (hist) (diff) CH391L/S2013 (→Due March 20, 2013)
- 16:36, 14 March 2013 (hist) (diff) CH391L/S2013 (→Due February 27, 2013)
- 13:58, 13 February 2013 (hist) (diff) User talk:Hala Ouzon-Shubeita (→CH391L/S2013 Hala Ouzon Feb 13 2013) (top)
- 02:37, 13 February 2013 (hist) (diff) User:Hala Ouzon-Shubeita (→CH391L/S2013 Hala Ouzon Feb 13 2013)
- 02:36, 13 February 2013 (hist) (diff) User:Hala Ouzon-Shubeita (→Education)
- 02:29, 13 February 2013 (hist) (diff) CH391L/S2013 (→Due February 13, 2013)
- 02:25, 13 February 2013 (hist) (diff) User talk:Hala Ouzon-Shubeita (→CH391L/S2013 Hala Ouzon Feb 13 2013: new section)
- 02:08, 13 February 2013 (hist) (diff) N Image:Figure-Hala-2-1.jpg (top)
- 14:04, 10 February 2013 (hist) (diff) CH391L/S2013 (→Due February 13, 2013)
- 15:37, 30 January 2013 (hist) (diff) N CH391L/S2013 Hala Ouzon Jan 30 2013 (New page: Purified human BRCA2 stimulates RAD51-mediated recombination [4] '''Background:''' DNA integrity is essential to life. However DNA is constantly subject to assaults from endogenous speci...) (top)
- 15:35, 30 January 2013 (hist) (diff) CH391L/S2013 (→Due January 30, 2013)
- 15:33, 30 January 2013 (hist) (diff) User talk:Hala Ouzon-Shubeita (→CH391L/S2013 Hala Ouzon Jan 30 2013: new section)
- 18:10, 25 January 2013 (hist) (diff) CH391L/S2013 (→Due January 30, 2013)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
